ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 810,56
1,49%
DAX
18 518,03
-0,44%
Brent Oil
83,325
-1,20%
Bitcoin
64 394,71
-0,70%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
29/09/200522h05Business WireInsmed Provides Update on iPlex Pivotal Trial Data in Severe Primary IGF-1 DeficiencyNASDAQ:INSMInsmed Inc
29/09/200512h45Business WireInsmed Issues Statement Regarding IPLEX(TM) Approvable Letter Press ReleaseNASDAQ:INSMInsmed Inc
28/09/200500h55Business WireInsmed Receives Approvable Letter for iPlex(TM); Conference Call Tomorrow at 8:00am ESTNASDAQ:INSMInsmed Inc
19/09/200515h42Business WireSomatoKine(R) Pivotal Data to Be Featured in a Podium Presentation at the ESPE/LWPES 7th Joint Meeting of Pediatric EndocrinioloNASDAQ:INSMInsmed Inc
08/08/200522h05Business WireInsmed Incorporated Reports Financial Results for the Second Quarter and First Half of 2005NASDAQ:INSMInsmed Inc
02/08/200513h00Business WireInsmed to Release Second Quarter Financial Results; Monday, August 8NASDAQ:INSMInsmed Inc
10/06/200513h14Business WireFDA Extends PDUFA Date for SomatoKine to October 03, 2005NASDAQ:INSMInsmed Inc
31/05/200522h05Business WireInsmed Reports Detailed Positive Results from Its Pivotal Clinical Trial of SomatoKine in Patients with Growth Hormone InsensitiNASDAQ:INSMInsmed Inc
12/05/200515h59PR Newswire (US)/C O R R E C T I O N -- Insmed Inc./NASDAQ:INSMInsmed Inc
11/05/200500h00PR Newswire (US)Insmed Incorporated Reports Financial Results for First Quarter of 2005NASDAQ:INSMInsmed Inc
05/05/200515h01PR Newswire (US)Insmed Inc. to Webcast First Quarter Earnings Conference Call Thursday, May 12 at 8:30 a.m. (ET)NASDAQ:INSMInsmed Inc
26/04/200515h30PR Newswire (US)Insmed Initiates Phase II Trial With SomatoKine(R) in Type A Extreme Insulin ResistanceNASDAQ:INSMInsmed Inc
20/04/200515h01PR Newswire (US)Insmed Initiates Phase II HIV-Associated Lipodystrophy Trial With Somatokine(R)NASDAQ:INSMInsmed Inc
18/04/200522h03PR Newswire (US)Patent Infringement Suit Against Insmed DismissedNASDAQ:INSMInsmed Inc
26/10/200401h01PR Newswire (US)Insmed Receives European Orphan Drug Designation for SomatoKine for the Treatment of Extreme Insulin Resistance; Company to InitNASDAQ:INSMInsmed Inc
21/10/200423h01PR Newswire (US)Insmed and Tzamal Pharma Announce Agreement for the Promotion and Distribution of SomatoKine in Middle Eastern Territories; TzamNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
EU
AI
Air Liquide
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
VK
Vallourec
EU
BN
Danone
EU
BNP
BNP Paribas
EU
DG
Vinci
EU
MC
Lvmh Moet Hennessy Louis...
EU
ORA
Orange
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés